PNC Financial Services Group
ALDX icon

PNC Financial Services Group’s Aldeyra Therapeutics ALDX Stock Holding History

PNC Financial Services Group’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.35K Buy
1,575
+1,206
+327% +$2.07K ﹤0.01% 4531
2026
Q1 		$624 Sell
369
-177
-32% -$775 ﹤0.01% 4864
2025
Q4 		$2.83K Sell
546
-467
-46% -$2.4K ﹤0.01% 4438
2025
Q3 		$5.29K Buy
1,013
+472
+87% +$2.46K ﹤0.01% 4181
2025
Q2 		$2.07K Buy
541
+447
+476% +$1.16K ﹤0.01% 4397
2025
Q1 		$541 Buy
94
+60
+176% +$355 ﹤0.01% 4627
2024
Q4 		$170 Hold
34
– – ﹤0.01% 4661
2024
Q3 		$183 Hold
34
– – ﹤0.01% 4686
2024
Q2 		$113 Buy
+34
New +$133 ﹤0.01% 4712
2023
Q3 		– Sell
-246
Closed -$2.06K – 4608
2023
Q2 		$2.06K Hold
246
– – ﹤0.01% 4373
2023
Q1 		$2.44K Hold
246
– – ﹤0.01% 4258
2022
Q4 		$1.71K Hold
246
– – ﹤0.01% 4298
2022
Q3 		$1K Buy
+246
New +$1.48K ﹤0.01% 4279
2022
Q2 		– Sell
-40
Closed – – 4460
2022
Q1 		$0 Buy
+40
New +$159 ﹤0.01% 4500
2021
Q4 		– Sell
-248
Closed -$2K – 4426
2021
Q3 		$2K Buy
248
+197
+386% +$1.81K ﹤0.01% 4077
2021
Q2 		$1K Buy
+51
New +$613 ﹤0.01% 4083

Other funds holding ALDX

KCM
Knoll Capital Management Miami, Florida $214M AUM 62.74% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

PNC Financial Services Group's ALDX Position: Q2 2026 in Review

PNC Financial Services Group increased its Aldeyra Therapeutics (ALDX) stake by 327% in Q2 2026, buying an estimated $2.07K and bringing the position to 1,575 shares worth $3.35K. The position accounts for ﹤0.01% of the portfolio, ranked #4531.

PNC Financial Services Group first reported a position in ALDX in Q2 2021 and has held it in 16 quarters since. The position peaked at $5.29K in Q3 2025. 107 funds tracked by Wall St. Rank hold ALDX as of Q2 2026.

  • PNC Financial Services Group held 1,575 shares of Aldeyra Therapeutics worth $3.35K as of Q2 2026.
  • PNC Financial Services Group bought 1,206 Aldeyra Therapeutics shares in Q2 2026, an estimated $2.07K.
  • Aldeyra Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4531 holding.
  • PNC Financial Services Group first reported a position in Aldeyra Therapeutics in Q2 2021 and has held it in 16 quarters since.
  • PNC Financial Services Group's Aldeyra Therapeutics position peaked at $5.29K in Q3 2025.
  • 107 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.